CONMED
CNMD
263 hedge funds and large institutions have $4.8B invested in CONMED in 2023 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 78 increasing their positions, 99 reducing their positions, and 19 closing their positions.
168% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 19
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
27% more capital invested
Capital invested by funds: $3.77B → $4.8B (+$1.02B)
13% more funds holding
Funds holding: 232 → 263 (+31)
3.52% less ownership
Funds ownership: 119.07% → 115.54% (-3.5%)
21% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 99
63% less call options, than puts
Call options by funds: $11.7M | Put options by funds: $31.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$50.1M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$28.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$25.1M |
| 4 |
Bank of New York Mellon
New York
|
+$16.3M |
| 5 |
Millennium Management
New York
|
+$12.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
-$60.4M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$36.2M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$33.8M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$19.8M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$19.7M |
CNMD Hedge Fund Activity: Q2 2023 in Review
263 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2023, worth a combined $4.8B — up 27% from $3.77B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new CNMD positions and 19 closed out — a net gain of 32 holders — while 78 added to existing stakes and 99 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $50.1M. The largest seller was EARNEST Partners, cutting an estimated $60.4M.
- 263 institutional investors held CONMED (CNMD) as of Q2 2023, up from 232 in Q1 2023.
- Funds reported $4.8B of CONMED stock for Q2 2023, up 27% quarter-over-quarter.
- 51 funds opened new CONMED positions in Q2 2023 and 19 closed out, a net change of +32 holders.
- The largest CONMED buyer in Q2 2023 was Fidelity Investments, an estimated $50.1M added.
- The largest CONMED seller in Q2 2023 was EARNEST Partners, an estimated $60.4M sold.
Based on aggregated 13F filings for Q2 2023.